Facebook
Instagram
Twitter
YouTube
RSS Feed
LinkedIn
Flickr
California Institute for Regenerative Medicine
For Researchers
FUNDING OPPORTUNITIES
Information for Applicants
All Funding Opportunities
COVID-19
Discovery
Translational
Clinical
Infrastructure
Education
Previous Funding Opportunities
GRANTS
Active Awards Portfolio Dashboard
CIRM Grants
Managing Your Grant
CIRM Grantees
CIRM-Funded Institutions
CIRM Funding Commitments
Stem Cell Grant Regulations
CLINICAL RESOURCES
CIRM Funded Clinical Trials
Alpha Stem Cell Clinics
Cell and Gene Therapy Center
Collaborative Funding Partnerships
RESEARCH RESOURCES
FAQs for CIRM Awards
Industry Alliance Program
iPSC Repository
Genomics Initiative
CIRM Publications
Grantee Publications
Webinars and Workshops
hESC Cell Lines
For Patients
Patient Resources
CIRM Funded Clinical Trials
Alpha Stem Cell Clinics
Stem Cell Champions
Disease Programs
Stories of Hope
CIRM Stem Cellar Blog
Stem Cell Videos
Stem Cell Basics
Stem Cell Key Terms
Creating New Types of Stem Cells
Accelerating Research Towards Cures
California: The Leader in Stem Cell Research
From Lab Bench to Bedside
Myths and Misconceptions About Stem Cell Research
Stem Cell Tourism
The Power of Stem Cells
Patient Toolbox
Get Involved
Talking About CIRM
Jargon-Free Glossary
Media Interviews
Delivering the Perfect Presentation
Moderating a Panel
Serving on a Panel
Participating in Clinical Trials
Our Impact
Impact
Active Awards Dashboard
Funding Clinical Trials
Return on Investment
Creating Jobs
Creating Infrastructure
Growing the Field
Strategic Plan
Education
Internship programs (Bridges & SPARK)
Education Portal
Training Tomorrow's Scientists
Community
Stem Cell Champions
Stem Cell Awareness Day
Get Involved
About CIRM
About Us
Our Mission
Executive Team
CIRM Team Leads
Our History
2024 Annual Report
CIRM FAQ
Where CIRM funding goes
Job Opportunities
Contact Us
Governing Board
Public Meetings
CIRM Resources
Annual Report Archive
Strategic Plan
Funding Opportunities
Administrative Policies and Forms
News and Events
Newsroom
Meetings & Events
Public Meetings and Events
CIRM Board Meetings
Blog
Multimedia Resources
Podcast
Videos
Images
CIRM Fact Sheet
Logos
Contact Us
All CIRM Grants
Search Filters »
Disease Focus
(All)
aa Multiple Diseases (Centers & Resoures) (14)
Age-related macular degeneration (13)
Aging (22)
Alpha Thalassemia Major (3)
Alzheimer's Disease (35)
Amyotrophic Lateral Sclerosis (59)
Anemia (10)
Angelman Syndrome (1)
Arthritis (14)
Autism (23)
Autoimmune Disorder (1)
B cell cancers (12)
Beta Thalassemia (5)
Bladder or Urinary Tract Disorder (6)
Blood Cancer (73)
Blood Disorders (114)
Bone Marrow Transplant and Viral Infection (7)
Bone or Cartilage Disease (52)
Brain Cancer (35)
Brain Injury, hypoxic, ischemic (2)
Breast Cancer (9)
Canavan Disease (1)
Cancer (167)
Cartilage defect (4)
Colon Cancer (6)
Corneal Damage (7)
COVID-19 (23)
Cystic Fibrosis (3)
Cystinosis (3)
Danon Disease (4)
Dementia (5)
Developmental Disorders (23)
Diabetes (53)
Diabetic Wounds (2)
Duchenne Muscular Dystrophy (4)
Epidermolysis Bullosa (3)
Epilepsy (12)
Fertility (13)
Genetic Disorder (41)
Hearing Loss (11)
Heart Disease (105)
Heart disease associated with Duchenne muscular dystrophy (2)
Heart failure (12)
Hemophilia A (2)
HIV-related Lymphoma (2)
HIV/AIDS (42)
Huntington's Disease (37)
Hyper IgM Syndrome (2)
Hypertension, pulmonary arterial (2)
Immune Disease (57)
Incontinence (2)
Infectious Disease (55)
Inflammatory bowel disease (1)
Intellectual Disability (5)
Intervertebral disc degeneration (2)
Intestinal Disease (16)
IPEX Syndrome (5)
Kidney Disease (17)
Kidney Failure (14)
Leukemia (10)
Leukemia, Acute Myeloid (AML) (23)
Leukocyte Adhesion Deficiency (2)
Liver Disease (22)
Lung Cancer (6)
Lung Disease, Fibrosis (5)
Lupus, Systemic Lupus Erythematosus (SLE) (2)
Melanoma (13)
Metabolic Disorders (89)
Multiple Myeloma (8)
Multiple Sclerosis (9)
Muscle Injury (3)
Muscular Dystrophy (25)
N/A (441)
Neurological Disorders (311)
Neuropathy (5)
Osteoarthritis (6)
Osteonecrosis (3)
Other (19)
Ovarian Cancer (9)
Pancreatic Cancer (4)
Parkinson's Disease (52)
Pediatrics (74)
Prostate Cancer (7)
Pulmonary Hypertension (4)
Respiratory Disorders (28)
Retinitis Pigmentosa (11)
Rett's Syndrome (7)
Sanfilippo Syndrome/MPS III (2)
Sarcoma (4)
Severe Combined Immunodeficiency, Adenosine deaminase-deficient (ADA-SCID) (4)
Severe Combined Immunodeficiency, Artemis deficient (ART-SCID) (4)
Severe Combined Immunodeficiency, X-linked (X-SCID) (8)
Sickle Cell Disease (23)
Skeletal/Smooth Muscle disorders (45)
Skin cancer (2)
Skin Disease (19)
Solid Tumors (93)
Spina Bifida (5)
Spinal Cord Injury (42)
Spinal Muscular Atrophy (9)
Stroke (29)
Tendon/Ligament/Connective Tissue Injury or Disorder (3)
Thymic Disorder, 22q11 Deletion/DiGeorge (1)
Toxicity (7)
Trauma (10)
Traumatic Brain Injury (5)
Type 1 diabetes (21)
Vascular Disease (17)
Vision Loss (66)
Wounds, ulcers (3)
X-linked Chronic Granulomatous Disease (3)
Zika virus (3)
Institution
(All)
AcuraStem Incorporated (2)
Adjuvant Partners, LLC (1)
Adverum Biotechnologies (1)
Ali Nsair (1)
Alliance Forum Foundation (4)
Allogene Therapeutics (1)
Alto Neuroscience (1)
American Association of Blood Banks (2)
American Institute of Chemical Engineers (AIChE) (1)
Angiocrine Bioscience, Inc. (4)
Ankasa Regenerative Therapeutics, Inc. (2)
Aspen Neuroscience (2)
Aspera Biomedicines, Inc. (1)
Axent Biosciences Inc. (1)
Benjamin D. Yu (1)
Berkeley City College (2)
Biocom Institute (1)
BioEclipse Therapeutics INC. (1)
Biomedical Engineering Society (2)
BioTime, Inc. (1)
Bluebird Bio (1)
Boston Children’s Hospital (1)
Brain Mapping Foundation (2)
Brain Neurotherapy Bio (1)
BrainStorm Cell Therapeutics (1)
BrainXell Therapeutics (2)
Buck Institute for Age Research (9)
Cal Poly Corporation, an Auxiliary of California Polytechnic State University, San Luis Obispo (4)
Cal Poly Pomona Foundation (1)
Cal State Univ, Fullerton (4)
Cal State Univ, Long Beach (3)
Cal State Univ, Sacramento (3)
Cal State Univ, San Bernadino (4)
Caladrius Biosciences (2)
Calibr (3)
Calidi Biotherapeutics, Inc. (1)
California Institute of Technology (5)
California State University San Marcos Corporation (7)
California State University, Channel Islands (3)
Calimmune, Inc. (1)
Capricor, Inc (2)
Cedars-Sinai Medical Center (45)
Cellerant Therapeutics, Inc. (1)
Cellular Biomedicine Group, Inc. (1)
Cellular Dynamics International (1)
Celularity Inc. (1)
Chardan (1)
Charles R. Drew University of Medicine and Science (1)
Children’s Hospital of Los Angeles (18)
Children’s Hospital of Orange County (2)
Children’s Neurobiological Solutions (CNS) Foundation (1)
City College Of San Francisco (3)
City of Hope, Beckman Research Institute (59)
Combangio, Inc. (1)
Cytonus Therapeutics, Inc. (1)
Defined Bioscience, Inc. (1)
Elpida Therapeutics (1)
Escape Therapeutics, Inc (1)
Eureka Therapeutics, Inc. (1)
EVERSANA (1)
ExCellThera Inc. (1)
Excision BioTherapeutics (1)
Fate Therapeutics, Inc. (2)
Fluidigm Corporation (2)
Forty Seven Inc. (2)
FUJIFILM Cellular Dynamics (1)
Gamma Medica-Ideas, Inc. (1)
Genascence Corporation (1)
Geron Corporation (2)
Gladstone Institutes, J. David (39)
Global Genes (1)
GMR Epigenetics (1)
Gordon Research Conferences (3)
Greenstone Biosciences, Inc. (3)
HEALIOS NA, Inc. (1)
Humacyte, Inc. (2)
Human BioMolecular Research Institute (4)
Human Organ Project (1)
Humboldt State University Sponsored Programs Foundation (4)
ImmPACT-Bio, Inc. (1)
Immune-Onc Therapeutics (1)
ImmunoCellular Therapeutics (1)
ImmunoVec (3)
Immusoft Corporation (2)
Int. Soc. for Cell Gene Ther. (1)
Intact Therapeutics, Inc. (1)
International Alliance for Biological Standardization (1)
International Society for Experimental Hematology (1)
International Society for Stem Cell Research (6)
International Symposium on Neural Regeneration, Inc. (1)
iPierian, Inc. (2)
IQVIA, Inc. (2)
Jackson Labs (1)
Jasper Therapeutics, Inc. (1)
jCyte, Inc (2)
JDRF International (2)
Juvena Therapeutics Inc. (1)
Kenai Therapeutics (1)
Keystone Symposia on Molecular and Cellular Biology (3)
La Jolla Institute for Allergy and Immunology (1)
Lineage Cell Therapeutics, Inc. (3)
Loma Linda University (2)
Ludwig Institute for Cancer Research (3)
Lundquist Institute for Biomedical Innovation at Harbor – UCLA Medical Center (5)
Luxa Biotechnology (1)
Mahzi Therapeutics (2)
MAX BioPharma, Inc. (1)
Medeor Acquisition Corp. (1)
Midwinter Conference of Immunologists (3)
Minutia, Inc. (2)
MiraCosta College (1)
Mohammad Pashmforoush (1)
Mosaic Event Management, Inc. (1)
MyoGene Bio LLC (1)
Nammi Therapeutics, Inc. (1)
Nanotools Bioscience (1)
Navega Therapeutics (1)
Neurona Therapeutics (5)
Nexcella, Inc. (1)
Nohla Therapeutics Inc (1)
Novoglia, Inc. (2)
Numerate, Inc. (1)
OCTANe Foundation for Innovation (1)
Ocular Research Symposia Foundation, Inc. (1)
OncoMed Pharmaceuticals, Inc. (1)
Orchard Therapeutics plc (1)
Organos, Inc. (1)
Ossium Health, Inc. (1)
Palo Alto Veterans Institute for Research (6)
Parkinson’s Institute (5)
Pasadena City College (3)
Pathways to Stem Cell Science (1)
Poseida Therapeutics, Inc. (2)
Rampart Bioscience (1)
RARE-X (1)
Ray Therapeutics, INC (2)
Regencor, Inc. (1)
Regenerative Patch Technologies LLC (1)
Rejuvenate Bio (1)
Rejuvenation Technologies, Inc. (1)
Replay Holdings, Inc (1)
Research for Cure (1)
Reza Ardehali (1)
Rocket Pharmaceuticals, Inc. (3)
Rubedo Life Sciences Inc. (1)
Rumi Scientific CA (1)
RUNX1 Research Program (1)
Salk Institute for Biological Studies (25)
Samumed, LLC (1)
San Diego State University Foundation (5)
San Francisco State University (4)
SanBio, Inc. (1)
Sanford Burnham Prebys Medical Discovery Institute (28)
Sanford Consortium for Regenerative Medicine (8)
Sangamo BioSciences, Inc. (2)
Scaled Biolabs Inc. (1)
Scripps Health (5)
Scripps Research Institute (31)
Semma Therapeutics (1)
Senti Biosciences, Inc. (1)
Siren Biotechnology, Inc. (1)
SJSU Research Foundation (3)
Solano Community College (1)
St. Jude Children’s Research Hospital (1)
Stanford University (179)
StemCells, Inc. (3)
Summit for Stem Cell Foundation (1)
SynGAP Research Fund (1)
Tachyon Therapeutics, Inc (1)
Tenaya Therapeutics, Inc. (1)
The American Society of Gene & Cell Therapy (1)
The Biomedical Engineering Society (1)
The Regents of the University of California on behalf of its Riverside Campus (11)
The Scintillon Institute (2)
The Stone Research Foundation for Sports Medicine and Arthritis (1)
The University Corporation at California State University, Northridge (4)
Tippi C. Mackenzie (1)
Tr1X Inc. (1)
TriFoil Imaging, Inc. (1)
UCSF Benioff Children’s Hospital Oakland (8)
University of California, Berkeley (34)
University of California, Davis (77)
University of California, Irvine (72)
University of California, Los Angeles (163)
University of California, Merced (8)
University of California, San Diego (139)
University of California, San Francisco (125)
University of California, Santa Barbara (14)
University of California, Santa Cruz (16)
University of Southern California (53)
Vala Sciences, Inc. (1)
Vertuis Bio, Inc. (1)
ViaCyte, Inc. (9)
VistaGen Therapeutics, Inc. (1)
Vitabolus, Inc. (1)
Vitalant Research Institute (6)
VxBiosciences inc. (1)
Wake Forest University Health Sciences (1)
Western University of Health Sciences (1)
X-Therma Inc. (1)
Zenobia Therapeutics (1)
Program Type
(All)
Clinical (172)
Discovery (723)
Education (326)
Infrastructure (104)
Translation (156)
Grant Type
(All)
Accelerated Development Pathway I (1)
Accelerating Center (1)
Alpha Stem Cell Clinics (3)
Alpha Stem Cell Clinics Network Expansion (12)
Basic Biology I (12)
Basic Biology II (16)
Basic Biology III (27)
Basic Biology IV (28)
Basic Biology V (28)
Bridges (16)
Bridges (29)
Clinical Trial Stage Projects (3)
Clinical Trial Stage Projects (92)
COMPASS Training Grant (16)
Comprehensive Grant (29)
Conference (81)
Conference – 2024 CIRM Trainee Network Conference (1)
Conference – Lung Regenerative Medicine Workshop (1)
Conference – Manage a Symposium on Pluripotent Stem Cell Manufacturing (1)
Conference – Manage The 2016 Bridges And SPARK Annual Meetings (1)
Conference – Manage The Bridges Annual Meeting (4)
Conference – Manage The SPARK Annual Meeting (7)
Conference – The 2016 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The 2017 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The 2018 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The 2019 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The Alpha Stem Cell Clinic Annual Symposium (2)
Conference – The 2020 Grantee Meeting (1)
Conference II (84)
Creativity Awards (9)
Cure Sickle Cell Initiative Clinical Trial Stage Projects (3)
Diagnostic Translational Research Projects (3)
Discovery Research Projects (12)
Discovery Research Projects (1)
Disease Team Planning (22)
Disease Team Research I (15)
Disease Team Therapy Development – Research (12)
Disease Team Therapy Development III (6)
Disease Team Therapy Planning I (19)
Early Translational from Disease Team Conversion (3)
Early Translational I (16)
Early Translational II (24)
Early Translational III (21)
Early Translational IV (14)
Foundation – Discovery Stage Research Projects (39)
Genomics Centers of Excellence Awards (R) (3)
hiPSC Derivation (1)
hPSC Repository (1)
Inception – Discovery Stage Research Projects (39)
iPSC Consortia Award (1)
Late Stage Preclinical Projects (49)
Major Facilities (12)
Manufacturing Network Grant (9)
Medical Device Translational Research Projects (1)
New Cell Lines (18)
New Faculty I (26)
New Faculty II (24)
New Faculty Physician Scientist (15)
Patent Assistance Fund Awards (8)
Preclinical Development Awards (7)
Progression Award – Discovery Stage Research Projects (8)
Quest – Discovery Stage Research Projects (144)
ReMIND – Discovery Stage ReMIND (5)
Research Leadership (14)
Research Training Grant (18)
Research Training II (17)
SEED Grant (74)
Shared Labs (34)
SPARK (18)
Strategic Partnership I (2)
Strategic Partnership II (1)
Strategic Partnership III Track A (2)
Targeted Clinical Development (1)
Therapeutic Translational Research Projects (81)
Therapeutic Translational Research Projects (1)
Tissue Collection for Disease Modeling (7)
Tool Translational Research Projects (7)
Tools and Technologies I (23)
Tools and Technologies II (20)
Tools and Technologies III (22)
Training Grant I-1 (8)
Training Grant I-2 (5)
Training Grant I-3 (3)
Translating Center (1)
Transplantation Immunology (20)
Human Stem Cell Use
(All)
Adult or Tissue Stem Cell (318)
Cancer Stem Cell (46)
Directly Reprogrammed Cell (11)
Embryonic Stem Cell (389)
iPS Cell (303)
N/A (405)
Other (11)
SCNT (2)
Somatic Cell (30)
Vital Research Opportunity (3)
Cell Line Generation
(All)
Adult or Tissue Stem Cell (61)
Cancer Stem Cell (12)
Directly Reprogrammed Cell (2)
Embryonic Stem Cell (52)
iPS Cell (133)
N/A (1048)
Other (9)
SCNT (2)
Collaborative Funder
(All)
Andalusia, Spain (1)
Australia (3)
Canada (2)
France (1)
Germany (10)
Japan (1)
NIH (3)
United Kingdom (3)
Victoria, Australia (6)
Award Status
(All)
Active (348)
Closed (1115)
Pre-Active (18)
Institution
Researcher name
Grant Type
Grant Title
Award Value
University of Southern California
Dr. Mohammad Pashmforoush
New Faculty I
Transcriptional Regulation of Cardiac Pacemaker Cell Progenitors
$2,816,578
University of California, Berkeley
Dr. Irina M. Conboy
New Faculty I
Identification of hESC-mediated molecular mechanism that positively regulates the regenerative capacity of post-natal tissues
$2,246,020
University of California, Santa Cruz
Dr. Bin Chen
New Faculty I
Molecular mechanisms of neural stem cell differentiation in the developing brain
$2,147,592
University of California, Los Angeles
Dr. Kathrin Plath Dr.
New Faculty I
In vitro reprogramming of mouse and human somatic cells to an embryonic state
$2,229,427
The Regents of the University of California on behalf of its Riverside Campus
Dr. Douglas Ethell
New Faculty I
ES-Derived Cells for the Treatment of Alzheimer’s Disease
$621,639
Western University of Health Sciences
Dr. Douglas W Ethell
New Faculty I
ES-Derived Cells for the Treatment of Alzheimer’s Disease
$1,401,642
University of California, Davis
Dr. Chong-Xian Pan
New Faculty I
Combinatorial Chemistry Approaches to Develop LIgands against Leukemia Stem Cells
$2,386,409
University of California, Los Angeles
Dr. Hanna Mikkola
New Faculty I
Mechanisms of Hematopoietic stem cell Specification and Self-Renewal
$2,286,900
City of Hope, Beckman Research Institute
Dr. Tiziano Barberi
New Faculty I
Skeletal muscle development from hESC and its in vivo applications in animal models of muscular dystrophy
$131,840
Scripps Research Institute
Dr. Kristin K Baldwin Dr.
New Faculty I
Generating pluripotent cell lines from neurons.
$2,786,560
Salk Institute for Biological Studies
Dr. Lei Wang
New Faculty I
Genetic Encoding Novel Amino Acids in Embryonic Stem Cells for Molecular Understanding of Differentiation to Dopamine Neurons
$2,587,742
Stanford University
Dr. Anne Brunet
New Faculty I
Molecular mechanisms involved in adult neural stem cell maintenance
$2,348,435
University of California, Merced
Dr Jennifer O Manilay
New Faculty I
Enhancing Survival of Embryonic Stem Cell-Derived Grafts by Induction of Immunological Tolerance
$1,576,389
University of California, Irvine
Dr. Andrew Putnam
New Faculty I
A Novel Engineered Niche to Explore the Vasculogenic Potential of Embryonic Stem Cells
$395,764
Stanford University
Dr. Joanna Wysocka PhD
New Faculty I
Trithorax and Polycomb methyltransferase complexes in cell fate determination.
$2,373,903
University of California, San Diego
Dr. David Traver
New Faculty I
Genetic dissection of mesodermal commitment to the hematopoietic fates.
$2,150,620
University of Southern California
Dr. Songtao Shi
New Faculty I
Oral and Craniofacial Reconstruction Using Mesenchymal Stem Cells
$3,242,651
Scripps Research Institute
Dr. Sheng Ding Dr.
New Faculty I
Reprogramming of human somatic cells back to pluripotent embryonic stem cells
$1,393,876
Gladstone Institutes, J. David
Sheng Ding PhD
New Faculty I
Reprogramming of human somatic cells back to pluripotent embryonic stem cells
$1,320,101
Stanford University
Karl Deisseroth
New Faculty I
Bioengineering technology for fast optical control of differentiation and function in stem cells and stem cell progeny
$2,424,209
Stanford University
Dr. Howard Y. Chang
New Faculty I
Noncoding RNAs in Cell Fate Determination
$2,985,894
BioTime, Inc.
Dr. Michael D West Ph.D.
Early Translational I
Addressing the Cell Purity and Identity Bottleneck Through Generation and Expansion of Clonal Human Embryonic Progenitor Cell Lines
$4,721,706
University of California, Davis
Dr. Alice F Tarantal
Early Translational I
In Utero Model to Assess the Fate of Transplanted Human Cells for Translational Research and Pediatric Therapies
$3,143,392
Salk Institute for Biological Studies
Dr. Inder M. Verma
Early Translational I
Curing Hematological Diseases
$5,979,252
Sanford Burnham Prebys Medical Discovery Institute
Dr Evan Y Snyder
Early Translational I
Developmental Candidates for Cell-Based Therapies for Parkinson’s Disease (PD)
$5,190,752
Stanford University
Dr. Jill Helms
Early Translational I
Enhancing healing via Wnt-protein mediated activation of endogenous stem cells
$6,464,126
Jackson Labs
Pali G. Kaur
Early Translational I
Mouse Models for Stem Cell Therapeutic Development
$3,759,134
Gladstone Institutes, J. David
Dr. Warner C Greene
Early Translational I
Maximizing the Safety of Induced Pluripotent Stem Cells as an Infusion Therapy: Limiting the Mutagenic Threat of Retroelement Retrotransposition during iPSC Generation, Expansion and Differentiation
$1,280,001
Scripps Research Institute
Dr. Martin Friedlander
Early Translational I
Autologous Retinal Pigmented Epithelial Cells Derived from Induced Pluripotent Stem Cells for the Treatment of Atrophic Age Related Macular Degeneration
$5,806,321
University of California, Los Angeles
Dr. Gabriel H. Travis
Early Translational I
Development of a Stem Cell-based Transplantation Strategy for Treating Age-related Macular Degeneration
$5,487,136
Scripps Research Institute
Dr. Jeanne F Loring
Early Translational I
Ensuring the safety of cell therapy: a quality control pipeline for cell purification and validation
$5,830,771
ViaCyte, Inc.
Dr. Olivia G. Kelly
Early Translational I
Methods for detection and elimination of residual human embryonic stem cells in a differentiated cell product
$5,405,397
Scripps Health
Dr. Darryl D. D’Lima
Early Translational I
Stem Cell-Based Therapy for Cartilage Regeneration and Osteoarthritis
$3,118,431
University of California, Irvine
Dr. Frank LaFerla
Early Translational I
Neural Stem Cells as a Developmental Candidate to Treat Alzheimer Disease
$3,599,997
University of California, Davis
Dr. Jan Aileen Nolta PhD
Early Translational I
Sustained siRNA production from human MSC to treat Huntingtons Disease and other neurodegenerative disorders
$2,615,674
University of California, San Diego
Dr. Yang Xu
Early Translational I
Developing induced pluripotent stem cells into human therapeutics and disease models
$5,165,028
Parkinson’s Institute
Mr. James “Bill” William Langston Mr.
Early Translational I
Using patient-specific iPSC derived dopaminergic neurons to overcome a major bottleneck in Parkinson’s disease research and drug discovery
$3,698,646
University of California, Berkeley
Dr. Ellen A. Robey
Transplantation Immunology
Human Immune System Mouse models as preclinical platforms for stem cell derived grafts
$1,005,605
Scripps Research Institute
Dr. Nicholas R.J. Gascoigne
Transplantation Immunology
Role of Innate Immunity in hematopoeitic stem cell-mediated allograft tolerance
$1,705,554
Stanford University
Dr. Kenneth Weinberg
Transplantation Immunology
Engineered immune tolerance by Stem Cell-derived thymic regeneration
$1,271,729
University of California, Berkeley
Dr. David H Raulet
Transplantation Immunology
Inactivating NK cell reactivity to facilitate transplantation of stem cell derived tissue
$952,896
Stanford University
Dr. Robert Negrin MD
Transplantation Immunology
Regulatory T cell induced tolerance to ESC transplantation
$1,382,658
University of California, San Diego
Prof. Martin Marsala
Transplantation Immunology
Induction of immune tolerance after spinal grafting of human ES-derived neural precursors
$1,387,800
Cedars-Sinai Medical Center
Dr. Terrence Town
Transplantation Immunology
Role of HLA in neural stem cell rejection using humanized mice
$1,119,385
University of Southern California
Dr. Terrence Christopher Town
Transplantation Immunology
Role of HLA in neural stem cell rejection using humanized mice
$353,249
Stanford University
Professor Christopher H. Contag
Transplantation Immunology
Engineering Embryonic Stem Cell Allografts for Operational Tolerance
$1,411,338
University of California, San Diego
Dr. Yang Xu
Transplantation Immunology
Induction of immune tolerance to human embryonic stem cell-derived allografts
$1,192,680
University of California, Los Angeles
Dr. Gay Miriam Crooks
Transplantation Immunology
Engineering Thymic Regeneration to Induce Tolerance
$1,235,445
University of California, Davis
Dr. William J Murphy
Transplantation Immunology
Donor natural killer (NK) cells as “veto” cells to promote donor-specific tolerance
$1,257,601
Palo Alto Veterans Institute for Research
Dr. Husein Hadeiba
Transplantation Immunology
Application of Tolerogenic Dendritic Cells for Hematopoietic Stem Cell Transplantation
$733,061
« Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
…
30
Next »